腹腔镜Roux-en-Y胃旁路术与腹腔镜迷你胃旁路术治疗肥胖:随机对照试验研究方案
本研究为单中心、随机、患者与观察者盲法的非劣效性试验,计划纳入80例BMI 35–50 kg/m²且符合瑞士肥胖手术指南的成人,比较LRYGB与LMGB术后12个月多余体重减少百分比(EWL),并随访至36个月,评估 morbid 相关合并症缓解、生活质量及激素与血脂谱变化。
要点
- LRYGB被视为减重手术金标准,LMGB全球流行但缺乏随机对照试验比较。
- 主要终点为术后12个月EWL,非劣效性设计检验LMGB不劣于LRYGB。
- 样本量80例,随访至术后36个月,评估合并症缓解、生活质量及代谢指标。
核心结论
- 该随机对照试验将提供LMGB与LRYGB对EWL、合并症缓解、生活质量及激素与血脂谱影响的重要数据。
研究设计与样本
- 单中心、随机、患者与观察者盲法试验,采用非劣效性设计并据此计算样本量。
- 计划随机纳入80例18岁及以上、BMI 35–50 kg/m²且符合瑞士肥胖手术指南的肥胖患者。
- 主要终点为术后12个月EWL;次要终点包括3年EWL、发病率、死亡率、肥胖相关合并症缓解、生活质量及激素与血脂谱变化。
- 评估时间点为术前、术中及术后(出院时、术后6周、12个月和36个月)。
- 试验方案已获相关伦理委员会批准,临床试验注册号NCT02601092,注册日期2015年9月28日。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Laparoscopic Roux-en-Y gastric bypass (LRYGB) is considered the gold standard in bariatric surgery, achieving durable long-term weight loss with improvement of obesity-related comorbidities. Lately, the laparoscopic mini gastric bypass (LMGB) has gained worldwide popularity with similar results to LRYGB in terms of weight loss and comorbidity resolution. However, there is a lack of randomized controlled trials (RCT) comparing LMGB and LRYGB. This article describes the design and protocol of a randomized controlled trial comparing the outcomes of these two bariatric procedures. METHODS/DESIGN: The trial is designed as a single center, randomized, patient and observer blinded trial. The relevant ethics committee has approved the trial protocol. To demonstrate that LMGB is not inferior to LRYGB in terms of excess weight loss (EWL) the study is conducted as a non-inferiority trial with the sample-size calculations performed accordingly. EWL 12 months after surgery is the primary endpoint, whereas 3-year EWL, morbidity, mortality, remission of obesity related comorbidities, quality of life (QOL) and hormonal and lipid profile changes are secondary endpoints. Eighty patients, 18 years or older and with a body mass index (BMI) between 35 and 50 kg/m2 who meet the Swiss guidelines for the surgical treatment of morbid obesity will be randomized. The endpoints and baseline measurements will be assessed pre-surgery, peri-surgery and post-surgery (fixed follow up measurements are at discharge and at the time points 6 weeks and 12 and 36 months postoperatively). DISCUSSION: With its 3-year follow up time, this RCT will provide important data on the impact of LMGB and LRYGB on EWL, remission of comorbidities, QOL and hormonal and lipid profile changes. TRIAL REGISTRATION: ClinicalTrials.gov, NCT02601092 . Registered on 28 September 2015.
引用
- Kraljević M, Delko T, Köstler T, et al. Laparoscopic Roux-en-Y gastric bypass versus laparoscopic mini gastric bypass in the treatment of obesity: study protocol for a randomized controlled trial. Trials. 2017. PMID: 28532499. doi:10.1186/s13063-017-1957-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。